评估甲状腺功能测试结果与莱沃甲状腺素剂量在甲状腺功能低下症管理中的联系:我们可以改进剂量方案吗?
Adrian H Heald1,2, Lakdasa D Premawardhana3, Peter N Taylor3
1The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, England, UK.
Clinical endocrinology
|December 22, 2025
概括
利沃甲状腺激素治疗会改变甲状腺激素水平,只有43.8%的受治疗者处于TSH参考范围内. 临床医生在治疗甲状腺功能低下症时应考虑这些差异.
科学领域:
- 内分泌学 在内分泌学.
- 甲状腺学 甲状腺学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲状腺功能测试 (TFT) 是常见的,许多请求来自初级保健.
- 以前的研究表明,在接受Levothyroxine治疗的患者中,甲状腺激素水平低于最佳水平.
- 这项研究进一步调查了基于诊断和处方剂量的甲状腺激素水平差异.
研究的目的:
- 为了分析甲状腺激素水平 (TSH/FT4) 之间的差异,在莱沃西治疗的甲状腺功能低下症患者和未经治疗/甲状腺功能低下症患者之间.
- 为了检查Levothyroxine剂量如何影响这些甲状腺激素水平分布.
- 评估TSH参考范围内的受治疗个体的比例.
主要方法:
- 同时TSH/FT4的分析结果来自大量的人群记录 (47,869人接受治疗,393,101人未接受治疗).
- 纳入标准侧重于长期诊断的甲状腺功能低下患者,进行一致的测试,以及以甲状腺功能良好的人进行间隔测试.
- 数据按Levothyroxine药物剂量分层分类,并在人口群体之间进行比较.
主要成果:
- 与未接受治疗的个体相比,Levothyroxine治疗将FT4分布转移到更高的水平,TSH分布转移到低/无法检测的水平.
- 只有43.8%的接受治疗的人处于TSH参考范围内,而未接受治疗的人中只有90.3%.
- 较高的Levothyroxine剂量与TSH和FT4分布的较大偏差相关;男性和女性的中位数剂量不同.
结论:
- 甲状腺激素 (FT4/TSH) 的分布在接受Levothyroxine治疗和停止治疗的个体之间存在显著差异.
- 相当一部分接受Levothyroxine治疗的患者在TSH参考范围之外,剂量取决于变化.
- 临床医生必须意识到,Levothyroxine治疗可能无法恢复在无甲状腺患者中观察到的TSH/FT4平衡.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
Dose Size and Dosing Frequency: Determination Methods
244
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
244
Functions of Thyroid Hormones
4.9K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.9K
Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
194
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
194
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165


